Ad is loading...
GH
Price
$33.39
Change
+$2.41 (+7.78%)
Updated
Nov 22, 03:23 PM (EDT)
90 days until earnings call
PROF
Price
$7.52
Change
-$0.17 (-2.21%)
Updated
Nov 21 closing price
109 days until earnings call
Ad is loading...

GH vs PROF

Header iconGH vs PROF Comparison
Open Charts GH vs PROFBanner chart's image
Guardant Health
Price$33.39
Change+$2.41 (+7.78%)
Volume$1.8K
CapitalizationN/A
Profound Medical
Price$7.52
Change-$0.17 (-2.21%)
Volume$23.15K
CapitalizationN/A
GH vs PROF Comparison Chart
Loading...
GH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GH vs. PROF commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Buy and PROF is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (GH: $30.98 vs. PROF: $7.52)
Brand notoriety: GH: Notable vs. PROF: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 89% vs. PROF: 46%
Market capitalization -- GH: $2.46B vs. PROF: $205.33M
GH [@Medical Specialties] is valued at $2.46B. PROF’s [@Medical Specialties] market capitalization is $205.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whilePROF’s FA Score has 0 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • PROF’s FA Score: 0 green, 5 red.
According to our system of comparison, PROF is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 4 TA indicator(s) are bullish while PROF’s TA Score has 3 bullish TA indicator(s).

  • GH’s TA Score: 4 bullish, 6 bearish.
  • PROF’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GH is a better buy in the short-term than PROF.

Price Growth

GH (@Medical Specialties) experienced а +2.55% price change this week, while PROF (@Medical Specialties) price change was -6.13% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.22%. For the same industry, the average monthly price growth was +0.99%, and the average quarterly price growth was -2.23%.

Reported Earning Dates

GH is expected to report earnings on Feb 20, 2025.

PROF is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Medical Specialties (+3.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than PROF($205M). GH YTD gains are higher at: 14.529 vs. PROF (-11.425). PROF has higher annual earnings (EBITDA): -26.78M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. PROF (26.2M). PROF has less debt than GH: PROF (7.94M) vs GH (1.35B). GH has higher revenues than PROF: GH (564M) vs PROF (7.2M).
GHPROFGH / PROF
Capitalization2.47B205M1,202%
EBITDA-433.3M-26.78M1,618%
Gain YTD14.529-11.425-127%
P/E RatioN/AN/A-
Revenue564M7.2M7,834%
Total Cash1.17B26.2M4,462%
Total Debt1.35B7.94M17,051%
FUNDAMENTALS RATINGS
GH vs PROF: Fundamental Ratings
GH
PROF
OUTLOOK RATING
1..100
2170
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3861
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PROF's Valuation (50) in the null industry is in the same range as GH (75) in the Medical Or Nursing Services industry. This means that PROF’s stock grew similarly to GH’s over the last 12 months.

PROF's Profit vs Risk Rating (100) in the null industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that PROF’s stock grew similarly to GH’s over the last 12 months.

PROF's SMR Rating (98) in the null industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that PROF’s stock grew similarly to GH’s over the last 12 months.

GH's Price Growth Rating (38) in the Medical Or Nursing Services industry is in the same range as PROF (61) in the null industry. This means that GH’s stock grew similarly to PROF’s over the last 12 months.

GH's P/E Growth Rating (100) in the Medical Or Nursing Services industry is in the same range as PROF (100) in the null industry. This means that GH’s stock grew similarly to PROF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GHPROF
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
GH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMDVX20.560.28
+1.38%
Hartford Schroders US MidCap Opps A
VEIRX98.191.16
+1.20%
Vanguard Equity-Income Adm
TBDQX21.250.10
+0.47%
PGIM Jennison Diversified Growth R6
FTRIX26.420.11
+0.42%
Fidelity Advisor Mega Cap Stock I
MOWNX17.460.05
+0.29%
Moerus Worldwide Value N

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with VCYT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
+0.98%
VCYT - GH
50%
Loosely correlated
-0.66%
NVCR - GH
43%
Loosely correlated
+1.36%
TWST - GH
41%
Loosely correlated
+1.34%
HAE - GH
40%
Loosely correlated
+0.60%
BLFS - GH
39%
Loosely correlated
+1.52%
More

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and ALC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and ALC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
-2.21%
ALC - PROF
30%
Poorly correlated
+0.08%
LZAGY - PROF
29%
Poorly correlated
+0.12%
GH - PROF
27%
Poorly correlated
+0.98%
VCYT - PROF
24%
Poorly correlated
-0.66%
RDNT - PROF
24%
Poorly correlated
-1.05%
More